SEC
CLVS
Seven Eight Capital’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-69,791
| Closed | -$1.04M | – | 768 |
|
|
2019
Q2 | $1.04M | Buy |
+69,791
| New | +$1.04M | 0.05% | 391 |
|
|
2018
Q3 | – | Sell |
-10,606
| Closed | -$482K | – | 743 |
|
|
2018
Q2 | $482K | Buy |
10,606
+1,300
| +14% | +$59.1K | 0.03% | 363 |
|
|
2018
Q1 | $491K | Buy |
+9,306
| New | +$491K | 0.04% | 268 |
|
|
2017
Q3 | – | Sell |
-8,917
| Closed | -$835K | – | 661 |
|
|
2017
Q2 | $835K | Buy |
+8,917
| New | +$835K | 0.12% | 237 |
|
|
2017
Q1 | – | Sell |
-60
| Closed | -$3K | – | 719 |
|
|
2016
Q4 | $3K | Buy |
+60
| New | +$3K | ﹤0.01% | 554 |
|
|
2015
Q1 | – | Sell |
-300
| Closed | -$17K | – | 694 |
|
|
2014
Q4 | $17K | Buy |
+300
| New | +$17K | 0.03% | 367 |
|
|
2014
Q3 | – | Sell |
-200
| Closed | -$8K | – | 706 |
|
|
2014
Q2 | $8K | Buy |
+200
| New | +$8K | 0.01% | 471 |
|